IMNM Intrinsic Valuation and Fundamental Analysis - Immunome Inc - Alpha Spread

Watchlist Manager

Watchlist

Price: 18.76 USD -7.63% Market Closed

Market Cap: $2.2B

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Immunome Inc.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Immunome Does

Biotechnology Health Care

Immunome is a biotechnology company that tries to turn natural human antibodies into medicines. It uses its discovery technology to find antibodies from people who have fought off disease, then turns the strongest ones into drug candidates. The company focuses on diseases where targeted antibodies could block a harmful protein, with work in cancer and infectious disease.

Headquarters: United States of America US
Employees: 206
IPO date: Oct 2, 2020

Read the full company overview

How Immunome makes money

Drug development

Immunome uses its antibody discovery platform to find and develop new medicines, mainly for cancer and other serious diseases. The company works on its own drug candidates and may also advance programs with partners.

Customers: Patients through doctors if a medicine is approved, and pharmaceutical partners when Immunome licenses or collaborates on its programs.
Revenue Model: It can earn money from research collaboration payments, licensing deals, milestone payments, royalties, and, if a drug reaches the market, product sales or partner commercial payments.

View Company Overview

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

Continue IMNM Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 363,100+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.